Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Sophie Caillard and Samira Fafi-Kremer.
Sophie Caillard
Connection Strength
4.231
Samira Fafi-Kremer
  1. SARS-CoV-2 viral dynamics in immunocompromised patients. Am J Transplant. 2021 04; 21(4):1667-1669.
    View in: PubMed
    Score: 0.911
  2. Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19. Am J Transplant. 2021 11; 21(11):3808-3810.
    View in: PubMed
    Score: 0.239
  3. Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses. JAMA. 2021 Jul 23.
    View in: PubMed
    Score: 0.239
  4. Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19. Am J Transplant. 2021 08; 21(8):2871-2875.
    View in: PubMed
    Score: 0.238
  5. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021 06; 99(6):1498-1500.
    View in: PubMed
    Score: 0.235
  6. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Kidney Int. 2021 06; 99(6):1487-1489.
    View in: PubMed
    Score: 0.234
  7. Persistence of SARS-CoV-2 antibodies in kidney transplant recipients. Am J Transplant. 2021 06; 21(6):2307-2310.
    View in: PubMed
    Score: 0.231
  8. Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients. Transplantation. 2021 01 01; 105(1):158-169.
    View in: PubMed
    Score: 0.230
  9. Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol. 2021 01; 28(1):248-258.
    View in: PubMed
    Score: 0.227
  10. In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020 11; 20(11):3162-3172.
    View in: PubMed
    Score: 0.226
  11. First case of COVID-19 in a kidney transplant recipient treated with belatacept. Am J Transplant. 2020 Jul; 20(7):1944-1946.
    View in: PubMed
    Score: 0.220
  12. Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation. J Infect. 2019 07; 79(1):56-60.
    View in: PubMed
    Score: 0.206
  13. Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study. Transpl Infect Dis. 2019 Apr; 21(2):e13058.
    View in: PubMed
    Score: 0.203
  14. The Authors Reply. J Am Soc Nephrol. 2018 05; 29(5):1578.
    View in: PubMed
    Score: 0.189
  15. Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy. J Am Soc Nephrol. 2018 01; 29(1):326-334.
    View in: PubMed
    Score: 0.184
  16. Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients. J Infect Dis. 2021 02 24; 223(4):600-609.
    View in: PubMed
    Score: 0.058
  17. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology. 2020 09 29; 95(13):e1868-e1882.
    View in: PubMed
    Score: 0.056
  18. Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study. Radiology. 2020 11; 297(2):E242-E251.
    View in: PubMed
    Score: 0.055
  19. An unusually high substitution rate in transplant-associated BK polyomavirus in vivo is further concentrated in HLA-C-bound viral peptides. PLoS Pathog. 2018 10; 14(10):e1007368.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.